Abortion, Second Trimester
13
2
2
10
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
31%
4 trials in Phase 3/4
40%
4 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (13)
Cervical Preparation for Same-Day Dilation & Evacuation
Foley Balloon for Cervical Preparation Before Dilation and Evacuation
Simultaneous Mifepristone and Misoprostol Versus Misoprostol Alone for Induction of Labor of Nonviable Second Trimester Pregnancy: a Pilot Randomized Controlled Trial
Transcervical Balloon Compared to Osmotic Dilators Prior to Surgical Abortion
Induction of Abortion in the Second Trimester
Second-trimester TOP : a Retrospective Study Comparing Complications at 12-14 vs 14-16 Weeks of Gestation
Clotting Parameters After Medical Abortion
Overnight Pain Treatment Investigating Opioids vs. Nonopioids
24-hour Mifepristone and Buccal Versus Mifepristone and Vaginal Misoprostol for Cervical Preparation for D&E
Uterocervical Angle in the Termination of Second Trimester Pregnancy
Misoprostol With And Without Transcervical Balloon Catheter In Second Trimester Termination Of Pregnancy
Mifepristone and Mid-Trimester Termination of Pregnancy
A Pilot Study of Priming Before Induction Termination of Pregnancy